Small-molecule inhibitors of the PDZ domain of Dishevelled proteins interrupt Wnt signalling.


Journal

Magnetic resonance (Gottingen, Germany)
ISSN: 2699-0016
Titre abrégé: Magn Reson (Gott)
Pays: Germany
ID NLM: 101775538

Informations de publication

Date de publication:
2021
Historique:
received: 17 02 2021
accepted: 28 04 2021
medline: 2 6 2021
pubmed: 2 6 2021
entrez: 31 10 2023
Statut: epublish

Résumé

Dishevelled (Dvl) proteins are important regulators of the Wnt signalling pathway, interacting through their PDZ domains with the Wnt receptor Frizzled. Blocking the Dvl PDZ-Frizzled interaction represents a potential approach for cancer treatment, which stimulated the identification of small-molecule inhibitors, among them the anti-inflammatory drug Sulindac and Ky-02327. Aiming to develop tighter binding compounds without side effects, we investigated structure-activity relationships of sulfonamides. X-ray crystallography showed high complementarity of anthranilic acid derivatives in the GLGF loop cavity and space for ligand growth towards the PDZ surface. Our best binding compound inhibits Wnt signalling in a dose-dependent manner as demonstrated by TOP-GFP assays (IC

Identifiants

pubmed: 37904770
doi: 10.5194/mr-2-355-2021
pii: 01021829
pmc: PMC10539800
doi:

Types de publication

Journal Article

Langues

eng

Pagination

355-374

Informations de copyright

Copyright: © 2021 Nestor Kamdem et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Adv Ther (Weinh). 2019 Jul;2(7):1800143
pubmed: 32313833
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Nat Struct Biol. 1998 Jan;5(1):19-24
pubmed: 9437424
Science. 1999 Apr 30;284(5415):812-5
pubmed: 10221915
EMBO J. 2012 Jun 13;31(12):2737-46
pubmed: 22617421
Oncogene. 2003 Oct 16;22(46):7218-21
pubmed: 14562050
Cell. 1996 Aug 9;86(3):391-9
pubmed: 8756721
Cell. 1997 Mar 21;88(6):777-87
pubmed: 9118221
PLoS One. 2007 Sep 26;2(9):e953
pubmed: 17895993
PLoS One. 2011 Apr 18;6(4):e18329
pubmed: 21533126
Oncogene. 1999 Jan 28;18(4):979-85
pubmed: 10023673
Biol Cell. 2010 Aug 27;102(10):549-60
pubmed: 20626347
Mol Biol Cell. 2011 Sep;22(18):3344-54
pubmed: 21795396
Bioorg Med Chem. 2009 Feb 15;17(4):1701-8
pubmed: 19157887
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Curr Opin Cell Biol. 2013 Apr;25(2):254-64
pubmed: 23347562
Nature. 2008 Apr 3;452(7187):650-3
pubmed: 18385740
Bioorg Med Chem Lett. 2003 Mar 24;13(6):1093-6
pubmed: 12643919
Acc Chem Res. 2003 Jul;36(7):530-8
pubmed: 12859214
Development. 2005 Oct;132(20):4421-36
pubmed: 16192308
J Comput Aided Mol Des. 1997 Jul;11(4):333-44
pubmed: 9334900
J Med Chem. 2021 Feb 11;64(3):1423-1434
pubmed: 33502198
Chem Biol Drug Des. 2012 Apr;79(4):376-83
pubmed: 22172211
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Biopolymers. 1996 Mar;38(3):305-20
pubmed: 8906967
Int J Colorectal Dis. 2011 Oct;26(10):1279-85
pubmed: 21670985
Gastroenterology. 2009 Jul;137(1):165-75
pubmed: 19328798
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Bioorg Med Chem Lett. 1999 Jul 5;9(13):1869-74
pubmed: 10406657
Nat Commun. 2015 Apr 24;6:6718
pubmed: 25907794
Exp Cell Res. 2015 Feb 1;331(1):115-122
pubmed: 25445788
Gut. 2010 Dec;59(12):1680-6
pubmed: 20926645
Chem Sci. 2021 Jan 6;12(6):2286-2293
pubmed: 34163995
Nat Rev Cancer. 2008 May;8(5):387-98
pubmed: 18432252
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Angew Chem Int Ed Engl. 2009;48(35):6448-52
pubmed: 19637179
ACS Chem Neurosci. 2021 Jan 6;12(1):244-255
pubmed: 33356131
Bioorg Med Chem. 2010 Jul 1;18(13):4606-14
pubmed: 20627597
Science. 1996 Nov 29;274(5292):1531-4
pubmed: 8929414
Cell. 1996 Jun 28;85(7):1067-76
pubmed: 8674113
Biochemistry. 2003 Mar 18;42(10):2797-805
pubmed: 12627945
Nat Commun. 2019 Oct 4;10(1):4521
pubmed: 31586061
Biochem Biophys Res Commun. 2017 Apr 8;485(3):584-590
pubmed: 27932247
Chem Biol. 2006 Dec;13(12):1247-51
pubmed: 17185220
Bioorg Med Chem. 2008 Apr 1;16(7):3519-29
pubmed: 18316193
Cancer Res. 2007 Jan 15;67(2):573-9
pubmed: 17234765
Science. 1997 Jan 3;275(5296):73-7
pubmed: 8974395
EMBO Mol Med. 2020 Jun 8;12(6):e11248
pubmed: 32352640
J Med Chem. 2000 Jan 27;43(2):156-66
pubmed: 10649971
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
pubmed: 11274893
J Biol Chem. 2009 Jun 12;284(24):16256-16263
pubmed: 19383605
J Chem Inf Model. 2010 Apr 26;50(4):470-9
pubmed: 20297844
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Protein Sci. 2009 May;18(5):994-1002
pubmed: 19388021
Cancer Cell. 2002 Apr;1(3):279-88
pubmed: 12086864
Biochem Biophys Res Commun. 1997 Oct 20;239(2):510-6
pubmed: 9344861
Chem Biol. 2004 Apr;11(4):449-59
pubmed: 15123239
Bioessays. 1997 Jun;19(6):469-79
pubmed: 9204764
Biochemistry. 2005 Nov 29;44(47):15495-503
pubmed: 16300398
Cancer Res. 2003 Aug 1;63(15):4547-51
pubmed: 12907630
Curr Biol. 1996 Nov 1;6(11):1385-8
pubmed: 8939589
Nat Struct Mol Biol. 2007 Jun;14(6):484-92
pubmed: 17529994
Nat Chem Biol. 2009 Apr;5(4):217-9
pubmed: 19252499
Bioorg Med Chem. 2016 Aug 1;24(15):3259-66
pubmed: 27112452
Br J Pharmacol. 1998 Jun;124(3):556-62
pubmed: 9647481
Nature. 1996 Aug 15;382(6592):638-42
pubmed: 8757136
Annu Rev Neurosci. 2001;24:1-29
pubmed: 11283303
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
ChemMedChem. 2011 Aug 1;6(8):1411-22
pubmed: 21626699
J Med Chem. 1999 Nov 4;42(22):4485-99
pubmed: 10579813
Biochemistry. 1997 Apr 15;36(15):4393-8
pubmed: 9109646
Curr Pharm Des. 2006;12(31):3963-72
pubmed: 17100607
Tumori. 2005 Nov-Dec;91(6):546-51
pubmed: 16457155
Front Pharmacol. 2018 Sep 05;9:983
pubmed: 30233369
Mol Cell. 2003 Nov;12(5):1251-60
pubmed: 14636582
Mol Cancer. 2010 Aug 06;9:212
pubmed: 20691072
Nat Struct Biol. 2000 Dec;7(12):1178-84
pubmed: 11101902
Mol Cell Biol. 2002 Feb;22(4):1172-83
pubmed: 11809808
Curr Opin Cell Biol. 2007 Apr;19(2):112-6
pubmed: 17317137
EMBO Mol Med. 2016 Mar 31;8(4):375-87
pubmed: 26941261
J Am Chem Soc. 2003 Sep 10;125(36):10941-6
pubmed: 12952475

Auteurs

Nestor Kamdem (N)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.

Yvette Roske (Y)

Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Dmytro Kovalskyy (D)

Enamine Ltd., Chervonotkatska Street 78, Kyiv 02094, Ukraine.
ChemBio Ctr, Taras Shevchenko National University of Kyiv, 62 Volodymyrska, Kyiv 01033, Ukraine.

Maxim O Platonov (MO)

Enamine Ltd., Chervonotkatska Street 78, Kyiv 02094, Ukraine.
ChemBio Ctr, Taras Shevchenko National University of Kyiv, 62 Volodymyrska, Kyiv 01033, Ukraine.

Oleksii Balinskyi (O)

Enamine Ltd., Chervonotkatska Street 78, Kyiv 02094, Ukraine.
ChemBio Ctr, Taras Shevchenko National University of Kyiv, 62 Volodymyrska, Kyiv 01033, Ukraine.

Annika Kreuchwig (A)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.

Jörn Saupe (J)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.

Liang Fang (L)

Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Anne Diehl (A)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Peter Schmieder (P)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Gerd Krause (G)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Jörg Rademann (J)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Straße 2 + 4, 14195 Berlin, Germany.

Udo Heinemann (U)

Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.
Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Walter Birchmeier (W)

Max Delbrück Center for Molecular Medicine, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Hartmut Oschkinat (H)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Institut für Chemie und Biochemie, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany.

Classifications MeSH